文献速递临床试验与 GCP流行病学与生物统计

综合行为减重治疗与问题解决治疗对肥胖合并抑郁患者体重指数和抑郁症状的影响:RAINBOW随机临床试验

Effect of Integrated Behavioral Weight Loss Treatment and Problem-Solving Therapy on Body Mass Index and Depressive Symptoms Among Patients With Obesity and Depression: The RAINBOW Randomized Clinical Trial.
PubMed 文献 · JAMA · 2019-01-01

RAINBOW随机临床试验纳入409名肥胖合并抑郁的初级保健患者,比较综合协作照护干预(整合行为减重、问题解决治疗及按需抗抑郁药)与常规照护。12个月时干预组BMI和抑郁症状较对照组有显著改善,但效应量适中且临床重要性不确定。

要点

  • 干预组12个月BMI较基线下降,对照组无变化,组间差异-0.7(95%CI -1.1至-0.2)。
  • 干预组SCL-20抑郁评分下降,对照组轻微变化,组间差异-0.2(95%CI -0.4至0)。
  • 干预组与对照组分别报告27例和20例涉及肌肉骨骼损伤的不良事件。

核心结论

  • 在肥胖合并抑郁成人中,整合行为减重、问题解决治疗及按需抗抑郁药的协作照护干预较常规照护显著改善12个月体重减轻和抑郁症状,但效应量适中且临床重要性不确定。

研究设计与样本

  • RAINBOW随机临床试验纳入409名BMI≥30(亚裔≥27)且PHQ-9≥10的成人,随机分为干预组204例和常规照护对照组205例。
  • 研究对象为北加州某健康系统的初级保健患者,招募时间2014年9月30日至2017年1月12日,最终12个月随访日期为2018年1月17日。

主要发现

  • 12个月时干预组平均BMI从36.7(SD 6.9)降至35.9(SD 7.1),对照组从36.6(SD 5.8)至36.6(SD 6.0),组间平均差异-0.7(95%CI -1.1至-0.2),P=.01。
  • 12个月时干预组平均SCL-20评分从1.5(SD 0.5)降至1.1(SD 1.0),对照组从1.5(SD 0.6)至1.4(SD 1.3),组间平均差异-0.2(95%CI -0.4至0),P=.01。
  • 共报告47例涉及肌肉骨骼损伤的不良事件或严重不良事件,其中干预组27例、常规照护组20例。

局限性

  • 效应量适中且临床重要性不确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Coexisting obesity and depression exacerbate morbidity and disability, but effective treatments remain elusive. OBJECTIVE: To test the hypothesis that an integrated collaborative care intervention would significantly improve both obesity and depression at 12 months compared with usual care. DESIGN, SETTING, AND PARTICIPANTS: The Research Aimed at Improving Both Mood and Weight (RAINBOW) randomized clinical trial enrolled 409 adults with body mass indices (BMIs) of 30 or greater (≥27 for Asian adults) and 9-item Patient Health Questionnaire (PHQ-9) scores of 10 or greater. Primary care patients at a health system in Northern California were recruited from September 30, 2014, to January 12, 2017; the date of final 12-month follow-up was January 17, 2018. INTERVENTIONS: All participants randomly assigned to the intervention (n = 204) or the usual care control group (n = 205) received medical care from their personal physicians as usual, received information on routine services for obesity and depression at their clinic, and received wireless physical activity trackers. Intervention participants also received a 12-month intervention that integrated a Diabetes Prevention Program-based behavioral weight loss treatment with problem-solving therapy for depression and, if indicated, antidepressant medications. MAIN OUTCOMES AND MEASURES: The co-primary outcome measures were BMI and 20-item Depression Symptom Checklist (SCL-20) scores (range, 0 [best] to 4 [worst]) at 12 months. RESULTS: Among 409 participants randomized (mean age of 51.0 years [SD, 12.1 years]; 70% were women; mean BMI of 36.7 [SD, 6.4]; mean PHQ-9 score of 13.8 [SD, 3.1]; and mean SCL-20 score of 1.5 [SD, 0.5]), 344 (84.1%) completed 12-month follow-up. At 12 months, mean BMI declined from 36.7 (SD, 6.9) to 35.9 (SD, 7.1) among intervention participants compared with a change in mean BMI from 36.6 (SD, 5.8) to 36.6 (SD, 6.0) among usual care participants (between-group mean difference, -0.7 [95% CI, -1.1 to -0.2]; P = .01). Mean SCL-20 score declined from 1.5 (SD, 0.5) to 1.1 (SD, 1.0) at 12 months among intervention participants compared with a change in mean SCL-20 score from 1.5 (SD, 0.6) to 1.4 (SD, 1.3) among usual care participants (between-group mean difference, -0.2 [95% CI, -0.4 to 0]; P = .01). There were 47 adverse events or serious adverse events that involved musculoskeletal injuries (27 in the intervention group and 20 in the usual care group). CONCLUSIONS AND RELEVANCE: Among adults with obesity and depression, a collaborative care intervention integrating behavioral weight loss treatment, problem-solving therapy, and as-needed antidepressant medications significantly improved weight loss and depressive symptoms at 12 months compared with usual care; however, the effect sizes were modest and of uncertain clinical importance. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02246413.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Ma J, Rosas LG, Lv N, et al. Effect of Integrated Behavioral Weight Loss Treatment and Problem-Solving Therapy on Body Mass Index and Depressive Symptoms Among Patients With Obesity and Depression: The RAINBOW Randomized Clinical Trial. JAMA. 2019. PMID: 30835308. doi:10.1001/jama.2019.0557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。